CD4+ T cell responses (CD4+OX40+41BB+) against SARS-CoV-2 spike and non-spike MPs were detectable in the majority of children with convalescent COVID-19 (95% and 75% with fold change [FC] over DMSO control > 2, respectively; Figure 1A). This evidence concerns the gene CD4 and COVID-19.